# Pennant Reports First Quarter 2026 Results
Canonical URL: https://biopharmsignal.com/news/PNTG/pennant-reports-first-quarter-2026-results
Ticker: PNTG
Company: Pennant Group
Source: Pennant Group
Published: 2026-05-06 20:05 EST
Original Source URL: https://investor.pennantgroup.com
## Summary

Conference Call and Webcast scheduled for tomorrow, May 7, 2026 at 10:00 am MT EAGLE, Idaho, May 06, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating

## Article Body
Conference Call and Webcast scheduled for tomorrow, May 7, 2026 at 10:00 am MT EAGLE, Idaho, May 06, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating
## Recent Company News
- 2026-06-03 11:00 EST — [Pennant Expands Senior Living Presence with Pleasant Hill, California Community](https://biopharmsignal.com/news/PNTG/pennant-expands-senior-living-presence-with-pleasant-hill-california-community) — Source: Pennant Group
- 2026-05-18 22:03 EST — [Pennant Group to Participate in the 2026 RBC Global Healthcare Conference](https://biopharmsignal.com/news/PNTG/pennant-group-to-participate-in-the-2026-rbc-global-healthcare-conference) — Source: Pennant Group
- 2026-05-18 21:22 EST — [Pennant Announces an Acquisition of Senior Living Community in Arizona](https://biopharmsignal.com/news/PNTG/pennant-announces-an-acquisition-of-senior-living-community-in-arizona) — Source: Pennant Group
- 2026-05-06 20:05 EST — [Pennant Reports First Quarter 2026 Results](https://biopharmsignal.com/news/PNTG/pennant-reports-first-quarter-2026-results) — Source: Pennant Group
- 2026-05-04 23:34 EST — [Pennant Announces First Quarter 2026 Earnings Release and Call](https://biopharmsignal.com/news/PNTG/pennant-announces-first-quarter-2026-earnings-release-and-call) — Source: Pennant Group
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)